echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Overview of the status of consistency evaluation (as of March 9)

    Overview of the status of consistency evaluation (as of March 9)

    • Last Update: 2019-03-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    the original title: The status quo of consistency evaluation (as of March 9)as of March 9, CDE accepted 325 varieties of consistency evaluation, a total of 350 pharmaceutical companies 1055 acceptance numbersA total of 103 varieties have been evaluated for consistency, with a total of 213 approval numbers for 88 pharmaceutical companiesconsistency evaluation declaration acceptance number of the top ten enterprises, is still familiar with the pharmaceutical enterprises, Yuanyi is Qilu PharmaceuticalThe future of the industry's enterprises are strong Hengqiang, or someone bendover overtaking later on the top?of the benzoic acid chlorpyrifos is the most declared varieties, 34 enterprises have declared, a total of 38 acceptance numbers, 6 enterprises throughAs a market of ten billion varieties, it is said that a province's agent margin of 1 million yuanthe industry spread the second batch of 40 varieties of quantity procurement basic selection, "customs clearance consistency evaluation" as a necessary entry ticket, so for pharmaceutical companies, consistency evaluation is still a compulsory courseaccording to the pre-judgment of the rice net, 18 varieties of qualified enterprises, large clinical drug use, comprehensive judgment selected in the second batch of collection of varieties list is relatively largeThey are: ampicillin, Acapone, paracetamol, volion, metformin, klinmycin, mosimatin, regline, gremetin, azithromycin, temequinone, cyclosporine, tansorosin, amoxicillin, kramycin, sorool, pyrethropinesis, ibuprofenthe road is tortuous, the future is bright, the future has come
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.